Nightingale Health consists of eight group companies, including subsidiaries in Japan, the United States, Singapore and the United Kingdom, with customers in more than 25 countries. The technology is being used in many of the world’s leading health initiatives, such as the UK Biobank, and there are over 400 peer-reviewed publications validating the technology.
We have recognized a strong demand for Nightingale Health’s technology in Japan, the country being one of the most advanced in the preventative side of health care. In 2019, Nightingale Health started to build a strong network in Japan and entered a strategic partnership with Mitsui & Co., a global trading and investment house, and Biobank Japan, one of the world’s largest hospital biobanks. The relationship between Mitsui and Nightingale Health is built on a shared vision that tools to prevent diseases impacting our quality of life should be made accessible for everyone.
Nightingale Health has worked with top medical scientists and world-leading medical research institutes for almost a decade, and we are pleased to see that the long-term work has now enabled us to provide this service as part of the Japanese health checkup system.
Teemu Suna, Chief Executive Officer and Founder of Nightingale Health
The company’s service is being provided through Welltus Inc., a Mitsui subsidiary, to hospitals and clinics across Japan. The “My Nightingale” test is available at more than 20 hospitals and clinics and will increase to around 100 from April this year. The test consists of an easy-to-understand Blood Health Score on a 100-point scale and five health indicators in the most relevant health areas. Results are reported in the My Nightingale mobile application in addition to the traditional reports.
“Nightingale Health has worked with top medical scientists and world-leading medical research institutes for almost a decade, and we are pleased to see that the long-term work has now enabled us to provide this service as part of the Japanese health checkup system,” said Teemu Suna, CEO and founder of Nightingale Health.
“We wish to see even broader use for our technology and service in the future, such as being part of well-being programs provided to employees and participating in different health initiatives on a national level,” continued Minja Salmio, vice president for Nightingale Health’s Japan operations.
Recently Welltus joined the Osaka Prefectural Government’s health initiative, Osaka Health Activity Mileage, which aims to promote the longevity of Osaka citizens and to bring down medical costs by introducing healthy habits for everyday life.
“With Nightingale Health’s technology and the My Nightingale test, individuals can measure the impact of their lifestyle and stay motivated to follow a healthier lifestyle. We have received very high praise from the medical community for My Nightingale, which is very easy for people to understand because it is scored on 100-point scale, and even offers advice on how to improve their scores, a unique feature that has not been available in previous health checkups,” said Welltus President Yasutaka Yamakawa.
Nightingale Health’s mission is to contribute to better preventative health on all levels — on the national health level, on the health care provider level and on the individual level. We are on this journey to make a long-term impact on the Japanese preventative health care system and to help people to pursue lifelong health.
